These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28704707)

  • 1. A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients.
    Ben-Khemis L; Mekki N; Ben-Mustapha I; Rouault K; Mellouli F; Khemiri M; Bejaoui M; Essaddam L; Ben-Becher S; Boughamoura L; Hassayoun S; Ben-Ali M; Barbouche MR
    Mol Immunol; 2017 Oct; 90():57-63. PubMed ID: 28704707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.
    Sassi A; Lazaroski S; Wu G; Haslam SM; Fliegauf M; Mellouli F; Patiroglu T; Unal E; Ozdemir MA; Jouhadi Z; Khadir K; Ben-Khemis L; Ben-Ali M; Ben-Mustapha I; Borchani L; Pfeifer D; Jakob T; Khemiri M; Asplund AC; Gustafsson MO; Lundin KE; Falk-Sörqvist E; Moens LN; Gungor HE; Engelhardt KR; Dziadzio M; Stauss H; Fleckenstein B; Meier R; Prayitno K; Maul-Pavicic A; Schaffer S; Rakhmanov M; Henneke P; Kraus H; Eibel H; Kölsch U; Nadifi S; Nilsson M; Bejaoui M; Schäffer AA; Smith CI; Dell A; Barbouche MR; Grimbacher B
    J Allergy Clin Immunol; 2014 May; 133(5):1410-9, 1419.e1-13. PubMed ID: 24698316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene.
    Lundin KE; Hamasy A; Backe PH; Moens LN; Falk-Sörqvist E; Elgstøen KB; Mørkrid L; Bjørås M; Granert C; Norlin AC; Nilsson M; Christensson B; Stenmark S; Smith CI
    Clin Immunol; 2015 Dec; 161(2):366-72. PubMed ID: 26482871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper-IgE syndromes: reviewing PGM3 deficiency.
    Yang L; Fliegauf M; Grimbacher B
    Curr Opin Pediatr; 2014 Dec; 26(6):697-703. PubMed ID: 25365149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report.
    Lundin KE; Wang Q; Hamasy A; Marits P; Uzunel M; Wirta V; Wikström AC; Fasth A; Ekwall O; Smith CIE
    BMC Pediatr; 2018 Aug; 18(1):285. PubMed ID: 30157810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment.
    Zhang Y; Yu X; Ichikawa M; Lyons JJ; Datta S; Lamborn IT; Jing H; Kim ES; Biancalana M; Wolfe LA; DiMaggio T; Matthews HF; Kranick SM; Stone KD; Holland SM; Reich DS; Hughes JD; Mehmet H; McElwee J; Freeman AF; Freeze HH; Su HC; Milner JD
    J Allergy Clin Immunol; 2014 May; 133(5):1400-9, 1409.e1-5. PubMed ID: 24589341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia.
    Stray-Pedersen A; Backe PH; Sorte HS; Mørkrid L; Chokshi NY; Erichsen HC; Gambin T; Elgstøen KB; Bjørås M; Wlodarski MW; Krüger M; Jhangiani SN; Muzny DM; Patel A; Raymond KM; Sasa GS; Krance RA; Martinez CA; Abraham SM; Speckmann C; Ehl S; Hall P; Forbes LR; Merckoll E; Westvik J; Nishimura G; Rustad CF; Abrahamsen TG; Rønnestad A; Osnes LT; Egeland T; Rødningen OK; Beck CR; ; Boerwinkle EA; Gibbs RA; Lupski JR; Orange JS; Lausch E; Hanson IC
    Am J Hum Genet; 2014 Jul; 95(1):96-107. PubMed ID: 24931394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.
    Ben-Farhat K; Ben-Mustapha I; Ben-Ali M; Rouault K; Hamami S; Mekki N; Ben-Chehida A; Larguèche B; Fitouri Z; Abdelmoula S; Khemiri M; Guediche MN; Boukthir S; Barsaoui S; Chemli J; Barbouche MR
    J Clin Immunol; 2016 Aug; 36(6):547-54. PubMed ID: 27220316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic features.
    García-García A; Buendia Arellano M; Deyà-Martínez À; Lozano Blasco J; Serrano M; Van Den Rym A; García-Solis B; Esteve-Solé A; Yiyi L; Vlagea A; Solanich X; Fisher MR; Lyons JJ; de Diego RP; Alsina L
    Pediatr Allergy Immunol; 2021 Apr; 32(3):566-575. PubMed ID: 33098103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Novel Homozygous Mutations in Phosphoglucomutase 3 Leading to Severe Combined Immunodeficiency, Skeletal Dysplasia, and Malformations.
    Fusaro M; Vincent A; Castelle M; Rosain J; Fournier B; Veiga-da-Cunha M; Kentache T; Serre J; Fallet-Bianco C; Delezoide AL; Renesme L; Picard FM; Lasseaux E; Aladjidi N; Seta N; Cormier-Daire V; Schaftingen EV; Neven B; Moshous D; Blesson S; Picard C
    J Clin Immunol; 2021 Jul; 41(5):958-966. PubMed ID: 33534079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development.
    Greig KT; Antonchuk J; Metcalf D; Morgan PO; Krebs DL; Zhang JG; Hacking DF; Bode L; Robb L; Kranz C; de Graaf C; Bahlo M; Nicola NA; Nutt SL; Freeze HH; Alexander WS; Hilton DJ; Kile BT
    Mol Cell Biol; 2007 Aug; 27(16):5849-59. PubMed ID: 17548465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel PGM3 Mutation Is Associated With a Severe Phenotype of Bone Marrow Failure, Severe Combined Immunodeficiency, Skeletal Dysplasia, and Congenital Malformations.
    Pacheco-Cuéllar G; Gauthier J; Désilets V; Lachance C; Lemire-Girard M; Rypens F; Le Deist F; Decaluwe H; Duval M; Bouron-Dal Soglio D; Kokta V; Haddad É; Campeau PM
    J Bone Miner Res; 2017 Sep; 32(9):1853-1859. PubMed ID: 28543917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior microphthalmia and nanophthalmia in Tunisia caused by a founder c.1059_1066insC mutation of the PRSS56 gene.
    Said MB; Chouchène E; Salem SB; Daoud K; Largueche L; Bouassida W; Benzina Z; Ayadi H; Söderkvist P; Matri L; Hmani-Aifa M
    Gene; 2013 Oct; 528(2):288-94. PubMed ID: 23820083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.
    Louhichi N; Triki C; Quijano-Roy S; Richard P; Makri S; Méziou M; Estournet B; Mrad S; Romero NB; Ayadi H; Guicheney P; Fakhfakh F
    Neurogenetics; 2004 Feb; 5(1):27-34. PubMed ID: 14652796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility Gene Card for: PGM3 defective congenital disorder of glycosylation.
    Jaeken J; Lefeber DJ; Matthijs G
    Eur J Hum Genet; 2019 Nov; 27(11):1757-1760. PubMed ID: 31231132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation.
    Wu G; Hitchen PG; Panico M; North SJ; Barbouche MR; Binet D; Morris HR; Dell A; Haslam SM
    Glycoconj J; 2016 Jun; 33(3):447-56. PubMed ID: 26687240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.
    Ben-Mustapha I; Ben-Farhat K; Guirat-Dhouib N; Dhemaied E; Larguèche B; Ben-Ali M; Chemli J; Bouguila J; Ben-Mansour L; Mellouli F; Khemiri M; Béjaoui M; Barbouche MR
    J Clin Immunol; 2013 May; 33(4):865-70. PubMed ID: 23314770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of settlement of villages from Central Tunisia by studying families sharing a common founder Glycogenosis type III mutation.
    Rhouma FB; Messai H; Hsouna S; Halim NB; Cherif W; Fadhel SB; Tiar A; Nagara M; Azzouz H; Sfar MT; Dridi MF; Tebib N; Ayadi A; Abdelhak S; Kefi R
    Mitochondrial DNA A DNA Mapp Seq Anal; 2016 Sep; 27(5):3194-8. PubMed ID: 26704523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segregation of S292F TPO gene mutation in three large Tunisian families with thyroid dyshormonogenesis: evidence of a founder effect.
    Bougacha-Elleuch N; Charfi N; Miled N; Bouhajja H; Belguith N; Mnif M; Jaurge P; Chikhrouhou N; Ayadi H; Hachicha M; Abid M
    Eur J Pediatr; 2015 Nov; 174(11):1491-501. PubMed ID: 25968604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic defects in the hexosamine and sialic acid biosynthesis pathway.
    Willems AP; van Engelen BG; Lefeber DJ
    Biochim Biophys Acta; 2016 Aug; 1860(8):1640-54. PubMed ID: 26721333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.